Moleculin Biotech Inc. (MBRX)
0.99
-0.16 (-13.91%)
At close: Mar 04, 2025, 9:46 AM
Moleculin Biotech Cash Flow Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Net Income | -29.77M | -29.02M | -15.89M | -17.36M | -13.21M | -11.88M | -9.8M | -3.93M | -748.36K |
Depreciation & Amortization | 127K | 130K | 164K | 200K | 199K | 68K | 18K | 6.16K | n/a |
Stock-Based Compensation | 1.98M | 2.27M | 2.37M | 1.68M | 1.54M | 1.14M | 707K | 411.47K | n/a |
Other Working Capital | 1.22M | -507K | 803K | 983K | -3.05M | 1.17M | 131K | 40.87M | 322.79K |
Other Non-Cash Items | 1.94M | -1.24M | 96K | 85K | 476K | -3.15M | 2.6M | 423.8K | 2.06K |
Deferred Income Tax | n/a | n/a | -6.73M | -2.34M | -4.06M | n/a | -1.39M | n/a | n/a |
Change in Working Capital | 1.62M | 224K | 1.04M | -41K | -2.14M | 1.61M | 542K | -256.18K | 322.79K |
Operating Cash Flow | -24.1M | -27.64M | -18.95M | -17.77M | -17.2M | -12.2M | -7.32M | -3.76M | -423.51K |
Capital Expenditures | -124K | -67K | -19K | -376K | -52K | -417K | -28K | -21.47K | n/a |
Acquisitions | n/a | n/a | n/a | 2K | 1K | n/a | n/a | -99.64K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 2.00 | 1.00 | n/a | n/a | n/a | n/a |
Investing Cash Flow | -124K | -67K | -19K | -374K | -51K | -417K | -28K | -121.11K | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -304.94K | 450K |
Common Stock Repurchased | n/a | -23 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 485K | -23K | 40K | -12K | 1.56M | 20K | 3.99M | -61 | n/a |
Financial Cash Flow | 4.65M | -23K | 74.72M | 22.55M | 20.85K | 12.04M | 10.06M | 8.87M | 451.6K |
Net Cash Flow | -19.59M | -27.76M | 55.73M | 4.44M | 3.6M | -580K | 2.71M | 4.98M | 28.09K |
Free Cash Flow | -24.23M | -27.71M | -18.97M | -18.15M | -17.25M | -12.62M | -7.35M | -3.79M | -423.51K |